Dabomb Protein (6578) — Cash Flow-to-Debt Ratio
Dabomb Protein (6578) has a Cash Flow-to-Debt Ratio of 0.00x as of December 2025, meaning its operating cash flow of NT$-354.00K could theoretically repay 0% of its total liabilities (NT$106.48 Million) in one year. Check 6578 total capital reinvestment ratio to assess the company's total reinvestment commitment from operating cash flow.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Dabomb Protein Cash Flow-to-Debt Ratio (2015–2025)
Historical debt coverage capacity for Dabomb Protein across 11 annual periods. Also explore Dabomb Protein total assets for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Dabomb Protein (2015–2025)
Year-by-year debt coverage analysis for Dabomb Protein. For market capitalisation and broader financial context, see 6578 market cap overview.
| Year | CF-to-Debt Ratio | Operating CF (TWD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.16x | NT$16.65 Million | NT$106.48 Million | ▼ -25.7% |
| 2024 | 0.21x | NT$47.55 Million | NT$225.96 Million | ▲ +1335.7% |
| 2023 | 0.01x | NT$6.51 Million | NT$443.83 Million | ▼ -58.9% |
| 2022 | 0.04x | NT$19.71 Million | NT$552.88 Million | ▲ +153.3% |
| 2021 | -0.07x | NT$-44.25 Million | NT$662.24 Million | ▼ -277.7% |
| 2020 | 0.04x | NT$13.41 Million | NT$356.66 Million | ▼ -75.0% |
| 2019 | 0.15x | NT$33.26 Million | NT$220.96 Million | ▼ -10.4% |
| 2018 | 0.17x | NT$22.07 Million | NT$131.39 Million | ▼ -12.6% |
| 2017 | 0.19x | NT$43.87 Million | NT$228.29 Million | ▼ -35.5% |
| 2016 | 0.30x | NT$59.58 Million | NT$200.11 Million | ▼ -70.8% |
| 2015 | 1.02x | NT$139.78 Million | NT$137.31 Million | — |